Published in J Allergy Clin Immunol on December 01, 1999
NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci U S A (2001) 2.33
Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest (2000) 2.05
Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med (2010) 1.68
Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. Thorax (2003) 1.16
Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol (2002) 1.15
Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies. Mediators Inflamm (2003) 0.80
Increase in exhaled nitric oxide (eNO) after work-related isocyanate exposure. Int Arch Occup Environ Health (2006) 0.78
Interferon-gamma regulates chemokine expression and release in the human mast cell line HMC1: role of nitric oxide. Immunology (2007) 0.77
Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J (2005) 5.24
Privately funded quality health care in India: a sustainable and equitable model. Int J Qual Health Care (2001) 3.65
Cloning and nucleotide sequencing of genes for three small, acid-soluble proteins from Bacillus subtilis spores. J Bacteriol (1986) 3.10
A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol (1999) 2.57
Cloning of a small, acid-soluble spore protein gene from Bacillus subtilis and determination of its complete nucleotide sequence. J Bacteriol (1985) 2.47
Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A (1995) 2.44
Predicting the difficult neuraxial block: a prospective study. Anesth Analg (1999) 2.43
NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci U S A (2001) 2.33
The cytoplasmic domain mediates localization of furin to the trans-Golgi network en route to the endosomal/lysosomal system. J Cell Biol (1994) 2.25
Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum (2008) 2.05
Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest (2000) 2.05
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J (2008) 1.99
The impact of thoracoscopy on the management of pleural disease. Chest (1995) 1.85
Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol (2000) 1.84
Regional variation in brain capillary density and vascular response to ischemia. Brain Res (2001) 1.82
The diagnostic and therapeutic utility of thoracoscopy. A review. Chest (1995) 1.75
Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol (2001) 1.69
Drug-induced lung disease. Cleve Clin J Med (2001) 1.63
Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest (1998) 1.60
Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertil Steril (1997) 1.59
Growth hormone and prolactin are paracrine growth and differentiation factors in the haemopoietic system. Immunol Today (1993) 1.58
Confusion of Legionella pneumophila and Mycobacterium tuberculosis. N Engl J Med (1979) 1.52
Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res (2001) 1.50
Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J Clin Invest (1997) 1.48
Pulmonary alveolar proteinosis: clinical features and outcomes. Chest (1998) 1.47
Determination of the chromosomal locations of four Bacillus subtilis genes which code for a family of small, acid-soluble spore proteins. J Bacteriol (1986) 1.46
Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension. Eur Respir J (2011) 1.46
Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther (2014) 1.45
Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet (2000) 1.43
Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am J Respir Crit Care Med (1998) 1.43
Pulmonary nitric oxide in mountain dwellers. Nature (2001) 1.40
Gender differences in mortality, quality of life and function after restorative procedures for rectal cancer. Colorectal Dis (2013) 1.40
Human vascular endothelial cells express oxytocin receptors. Endocrinology (1999) 1.40
Analysis of risk factors for myocardial infarction and cardiac mortality after major vascular surgery. Anesthesiology (2000) 1.29
Long-term outcome after laparoscopic and open surgery for rectal prolapse: a case-control study. Surg Endosc (2005) 1.27
Pulmonary alveolar proteinosis. Chron Respir Dis (2006) 1.25
Splicing function of mammalian U6 small nuclear RNA: conserved positions in central domain and helix I are essential during the first and second step of pre-mRNA splicing. Proc Natl Acad Sci U S A (1994) 1.22
Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol (1997) 1.21
Extracellular glutathione peroxidase induction in asthmatic lungs: evidence for redox regulation of expression in human airway epithelial cells. FASEB J (2001) 1.19
Repair of recurrent rectovaginal fistulas. Surgery (2001) 1.17
An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J (2011) 1.14
Biophysical properties and microfilament assembly in neutrophils: modulation by cyclic AMP. J Cell Biol (1991) 1.13
Clinical and electrographic manifestations of lesional neocortical temporal lobe epilepsy. Neurology (1997) 1.12
High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy. Lung (2001) 1.10
Polarity of human parainfluenza virus type 3 infection in polarized human lung epithelial A549 cells: role of microfilament and microtubule. J Virol (2001) 1.09
Decreased Cu,Zn-SOD activity in asthmatic airway epithelium: correction by inhaled corticosteroid in vivo. Am J Physiol (1997) 1.08
Central role of double-stranded RNA-activated protein kinase in microbial induction of nitric oxide synthase. J Immunol (2000) 1.08
Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur Respir J (2001) 1.08
Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma. Gene Ther (1999) 1.08
Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosis. Am J Respir Crit Care Med (1996) 1.07
Gene deletion of inositol hexakisphosphate kinase 2 predisposes to aerodigestive tract carcinoma. Oncogene (2009) 1.05
iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol (1998) 1.05
Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun (2005) 1.04
Alterations in exhaled gas profile during allergen-induced asthmatic response. Am J Respir Crit Care Med (2001) 1.04
Increased glutathione and glutathione peroxidase in lungs of individuals with chronic beryllium disease. Am J Respir Crit Care Med (1999) 1.03
Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Clin Immunol (2000) 1.02
The localizing value of ictal EEG in focal epilepsy. Neurology (2001) 1.02
Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. EMBO J (1996) 1.01
Smart sensor systems for human health breath monitoring applications. J Breath Res (2011) 0.99
Differential induction of extracellular glutathione peroxidase and nitric oxide synthase 2 in airways of healthy individuals exposed to 100% O(2) or cigarette smoke. Am J Respir Cell Mol Biol (2000) 0.99
Development of new cloning vectors for the production of immunogenic outer membrane fusion proteins in Escherichia coli. Biotechnology (N Y) (1996) 0.98
Variant forms of DNA polymerase beta in primary lung carcinomas. DNA Cell Biol (1999) 0.97
Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine (2000) 0.97
Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages. Am J Respir Cell Mol Biol (1999) 0.97
Mycobacterium kansasii endobronchial ulcer in a nonimmunocompromised patient. Respiration (2005) 0.97
Utility of peak expiratory flow monitoring. Chest (1998) 0.96
Biomarkers in exhaled breath condensate: a review of collection, processing and analysis. J Breath Res (2008) 0.95
Effect of the influenza A (H1N1) live attenuated intranasal vaccine on nitric oxide (FE(NO)) and other volatiles in exhaled breath. J Breath Res (2011) 0.95
Transbronchial needle aspiration for histology specimens. Chest (1989) 0.95
Nitric oxide, hypoxia, and superoxide: the good, the bad, and the ugly! Thorax (2005) 0.94